Questions?arveonix@protonmail.com•Telegram @arveonix

Last updated:

ARVEONIX Tesamorelin 10mg research product box and vial
Growth signalling · SKU TSM10

Tesamorelin 10mg

$100.00 AUD
In stock
Free shipping Australia-wideOrders over $150

Tesamorelin is a stabilised GHRH analogue studied in growth-hormone-releasing hormone receptor signalling and the GH/IGF-1 axis.

ProductTesamorelin 10mg
SKUTSM10
CategoryGrowth signalling
Listed price$100.00 AUD
AvailabilityIn stock
Confirm current availability when making an enquiry.

What is Tesamorelin?

Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH). It is designed to interact with the GHRH receptor and is researched for its effects on pituitary signalling and the broader growth-hormone/IGF-1 axis.

Because tesamorelin works through the GHRH pathway, it is distinct from ghrelin-receptor agonists such as Ipamorelin. Laboratory and clinical research literature therefore often examines it in the context of receptor-specific endocrine signalling.

Research category

Growth signalling

ARVEONIX format

Tesamorelin 10mg · SKU TSM10

Primary research context

GHRH receptor signalling

Catalogue status

In stock · $100.00 AUD

GHRH receptor signalling.

GHRH is an endogenous hypothalamic hormone involved in regulating pituitary growth-hormone release. Tesamorelin is a modified analogue studied for its ability to activate this receptor pathway.

Research may examine endocrine feedback, GH and IGF-1 signalling, receptor pharmacology and downstream metabolic markers. Interpretation should remain specific to the population and experimental design being studied.

Common research themes.

GHRH receptor

Receptor-specific research into hypothalamic-pituitary signalling.

GH/IGF-1 axis

Study of downstream endocrine signalling and feedback mechanisms.

Pituitary biology

Research into regulated release of growth hormone.

Pathway comparison

Useful for comparison with ghrelin-receptor agonists such as Ipamorelin.

Research considerations.

Research findings should always be interpreted within the experimental system in which they were produced. Cell, receptor, tissue, animal and human studies can answer different questions, and results from one model should not automatically be treated as established outcomes in another.

ARVEONIX product pages therefore focus on molecule identity, pathway biology and published research themes rather than presenting experimental observations as guaranteed effects. The information here is not a dosing, treatment or individual-use recommendation.

Tesamorelin FAQs.

What is Tesamorelin?

Tesamorelin is a synthetic GHRH analogue studied for signalling through the growth-hormone-releasing hormone receptor.

Is Tesamorelin the same as Ipamorelin?

No. Tesamorelin acts through the GHRH receptor pathway, while Ipamorelin is a ghrelin-receptor agonist.

What is the GH/IGF-1 axis?

It is an endocrine signalling network involving growth hormone, IGF-1 and feedback regulation between the hypothalamus, pituitary and peripheral tissues.

What areas of research involve Tesamorelin?

Research includes GHRH receptor pharmacology, pituitary signalling and GH/IGF-1 axis biology.

What strength is ARVEONIX Tesamorelin?

This catalogue product is listed as Tesamorelin 10mg under SKU TSM10.

Can the calculator be used for concentration arithmetic?

Yes. The ARVEONIX calculator can perform concentration and volume arithmetic from user-entered values.

Does this page recommend a dose?

No. It provides research information only.